News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Phylogica.
RELATED STOCKHEAD STORIES
Director Trades
Directors Trades: Upping the ante with $20m now in the game
Health & Biotech
Health: Opthea’s taking its successful anti-AMD drug to a 1,320 patient phase III trial; raises $50m
Health & Biotech
Dr Boreham’s Crucible: Can Phylogica finally make magic happen after nearly 15 years of trying?
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Health: EMVision has built its portable brain scanner, trial to begin imminently
Health & Biotech
Health: Zelda wants to buy a private US-based medicinal cannabis company
News
Rise & Shine: What you need to know before the ASX opens
Health & Biotech
Health: PainChek expands into Singapore with landmark deal
Health & Biotech
Phylogica shows its vaccine could cure the dreaded herpes disease
Health & Biotech
